摘要
目的:评价阿司匹林辅助瑞替普酶用于急性心肌梗死的疗效。方法:将60例急性心肌梗死患者随机分为2组,对照组30例给予瑞替普酶静脉滴注,观察组30例在静滴瑞替普酶的基础上加服阿司匹林,比较2组疗效。结果:经治疗后观察组ST段恢复、胸痛消失时间、2 h内出现再灌注心律失常情况、血清CK-MB酶峰值出现时间均优于对照组。结论:阿司匹林辅助瑞替普酶用于急性心肌梗死优于单用瑞替普酶者,值得推广。
Objective:To study clinical curative effect of aspirin and rPA union thrombolysis treatment in the acute myocardial infarction(AMI).Methods:60 example acute myocardial infarction(AMI) patients were divided into two groups stochastically,The control group 30 examples had the rPA intravenous infusion;The the observation group 30 examples were intravenous infusion rPA on the foundation of the aspirin,compared with two groups of clinical curative effects.Results:The aspirin and the rPA union medication to intravenous thrombolysis treatment had good curative effect.Conclusion:The aspirin and the rPA sole medication are sole medication remarkable,adverse reaction lower,are worth promoting.
出处
《现代临床医学》
2010年第4期267-268,共2页
Journal of Modern Clinical Medicine